Serum CA125 concentration has inverse correlation with metabolic syndrome

Journal of Korean Medical Science

Volumn 26, Issue 10, 2011, Pages 1328-1332

  Joo, Nam Seok ^a   Kim, Kyu Nam ^a   Kim, Kyung Soo ^b  

^a Ajou University School of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

CA 125; Korean; Metabolic syndrome

Indexed keywords

CA 125 ANTIGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MEMBRANE PROTEIN; MUC16 PROTEIN, HUMAN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD; FEMALE; HUMAN; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RISK FACTOR; SOUTH KOREA;

ADULT; AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; CHOLESTEROL, HDL; FEMALE; HUMANS; MEMBRANE PROTEINS; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; REPUBLIC OF KOREA; RISK FACTORS; TRIGLYCERIDES;

EID: 84863027103     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2011.26.10.1328     Document Type: Article

References (23)

1. Bast RC Jr, Xu FJ, Yu YH, Barnhill S, Zhang Z, Mills GB. CA 125: the past and the future. Int J Biol Markers 1998; 13: 179-87.
2. Verheijen RH, Von Mensdorff-Pouilly S, Van Kamp GJ, Kenemans P. CA 125: fundamental and clinical aspects. Semin Cancer Biol 1999; 9: 117-24.
3. Johnson CC, Kessel B, Riley TL, Ragard LR, Williams CR, Xu JL, Byus SS; Prostate, Lung, Colorectal and Ovarian Cancer Project Team. The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and ovarian cancer (PLCO) Screening Trial. Gynecol Oncol 2008; 110: 383-9.
4. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
5. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002; 156: 1070-7.
6. Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I. Serum highdensity lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 2004; 96: 1152-60.
7. Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 2002; 11: 385-91.
8. Michaud DS, Liu S, Giovannucci E, Willett WC, Colditz GA, Fuchs CS. Dietary sugar, glycemic load, and pancreatic cancer risk in a prospective study. J Natl Cancer Inst 2002; 94: 1293-300.
9. Olsen CM, Green AC, Whiteman DC, Sadeghi S, Kolahdooz F, Webb PM. Obesity and the risk of epithelial ovarian cancer: a systemic review and mea-analysis. Eur J Cancer 2007; 43: 690-709.
10. Bray F, Dos Santos Silva I, Moller H, Weiderpass E. Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention. Cancer Epidemiol Biomarkers Prev 2005; 14: 1132-42.
11. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Forcd Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet 2005; 366: 1059-62.
12. Kim MH, Kim MK, Choi BY, Shin YJ. Prevalence of the metabolic syndrome and its association with cardiovascular diseases in Korea. J Korean Med Sci 2004; 19: 195-201.
13. Ryu SY, Kweon SS, Park HC, Shin JH, Rhee JA. Obesity and the metabolic syndrome in Korean adolescents. J Korean Med Sci 2007; 22: 513-7.
14. Wolk A, Gridley G, Svensson M, Nyren O, McLaughlin JK, Fraumeni JF, Adam HO. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 2001; 12: 13-21.
15. McLemore MR, Miaskowski C, Aouizerat BE, Chen LM, Dodd MJ. Epidemiological and genetic factors associated with ovarian cancer. Cancer Nurs 2009; 32: 281-8.
16. Rodriguez C, Calle EE, Fakhrabadi-Shokoohi D, Jacobs EJ, Thun MJ. Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 2002; 11: 822-8.
17. Runnebaum IB, Stickeler E. Epidemiological and molecular aspects of ovarian cancer risk. J Cancer Res Clin Oncol 2001; 127: 73-9.
18. Nagle CM, Olsen CM, Webb PM, Jordan SJ, Whiteman DC, Green AC; Australian Cancer Study Group; Australian Ovarian Cancer Study Group. Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors. Eur J Cancer 2008; 44: 2477-84.
19. Olsen CM, Nagle CM, Whiteman DC, Purdie DM, Green AC, Webb PM; Australian Cancer Study (Ovarian Cancer) and Australian Ovarian Cancer Study Group. Body size and risk of epithelial ovarian and related cancers: a population-based case-control study. Int J Cancer 2008; 123: 450-6.
20. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D; Million Women Study Collaboration. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007; 335:1134.
21. Tania M, Khan MA, Song Y. Association of lipid metabolism with ovarian cancer. Curr Oncol 2010; 17: 6-11.
22. Vollmer RT, Humphrey PA. Tumor volume in prostate cancer and serum prostate-specific antigen. Analysis from a kinetic viewpoint. Am J Clin Pathol 2003; 119: 80-9.
23. Sarandakou A, Protonotariou E, Rizos D. Tumor markers in biological fluids associated with pregnancy. Crit Rev Clin Lab Sci 2007; 44: 151-78.